Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Investigational Breast Cancer Drug Could Boost Novartis’s Position
Marketwatch
Mon, 04/3/17 - 11:52 am
Tags:
breast cancer, Novartis, LEE011
Novartis' Lung Cancer Drug Combo Gets EU Nod
Investopedia
Mon, 04/3/17 - 09:19 am
Tags:
Novartis, Europe, metastatic non-small cell lung cancer, Tafinlar, Mekinist
How Novartis Is Aiming to Increase Entresto Sales in 2017
Market Realist
Fri, 03/31/17 - 10:06 am
Tags:
Novartis, Entresto, heart failure
Kickbacks judge to Novartis: Hand over the info on those 79,000 'sham' events
Fierce Pharma
Thu, 03/30/17 - 06:34 pm
Tags:
Novartis, physicians, kickbacks, DOJ
What Could Boost Medicare Demand for Novartis’s Entresto?
Market Realist
Thu, 03/30/17 - 10:55 am
Tags:
Novartis, Entresto, Medicare, heart failure
Novartis Makes Plans For Its Cancer-Killing T Cells
Forbes
Wed, 03/29/17 - 10:35 pm
Tags:
Novartis, CAR-T, Kite Pharma
Novartis’s Cosentyx Managed to Achieve Blockbuster Status in 2016
Market Realist
Wed, 03/29/17 - 09:31 am
Tags:
Novartis, Cosentyx, psoriasis
What Do Wall Street Analysts Expect for Novartis?
Market Realist
Wed, 03/29/17 - 09:00 am
Tags:
Novartis
Exploring Novartis’s 2016 Revenue
Market Realist
Sat, 03/25/17 - 12:10 pm
Tags:
Novartis, earnings
Sleuthy Google upstart Calico forges a rare biotech collaboration on aging with Novartis-backed C4
Endpoints
Fri, 03/24/17 - 09:39 am
Tags:
Google, Calico, biotech, C4 Therapeutics, Novartis
Novartis’ Heart Drug Fails Late Stage Trials
Investopedia
Wed, 03/22/17 - 11:13 am
Tags:
Novartis, serelaxin, acute heart failure
Novartis star Cosentyx, facing new rivals, may gain edge as a disease-modifying med
Fierce Pharma
Tue, 03/21/17 - 10:00 am
Tags:
Novartis, Cosentyx, psoriasis, Eli Lilly, Taltz, Valeant Pharmaceuticals, Siliq
Novartis Heart Failure Drug Beats Enalapril
Investopedia
Mon, 03/20/17 - 10:04 am
Tags:
Novartis, heart failure, Entresto, Enalapril
Novartis heart-failure med Entresto cuts A1c, insulin starts in diabetics: analysis
Fierce Pharma
Sun, 03/19/17 - 11:23 am
Tags:
Entresto, Novartis, diabetes, insulin
Will Pfizer's Growth Be Threatened by Novartis' New Cancer Drug?
Motley Fool
Wed, 03/15/17 - 09:52 pm
Tags:
Novartis, Pfizer, breast cancer, Ibrance, Kisqali
Turning Pfizer Discards Into Novartis Gold: The Story Of Ziarco
Forbes
Wed, 03/15/17 - 10:20 am
Tags:
Pfizer, Novartis, drug development, Ziarco, ZPL-389, R&D
Watch out Pfizer, Novartis’ LEE011 bags quick OK for frontline use against breast cancer
Endpoints
Tue, 03/14/17 - 09:38 am
Tags:
Pfizer, Novartis, LEE011, Ibrance, ribociclib, Kisqali, breast cancer
Despite hype, still much to uncover about immunotherapy
BioPharma Dive
Sat, 03/11/17 - 11:49 am
Tags:
immunotherapy, immuno-oncology, Novartis
Celgene, BMS, Novartis expected to top 2022 orphan drug market worth $209B: report
Fierce Pharma
Sat, 03/4/17 - 01:59 pm
Tags:
Celgene, Novartis, Bristol-Myers Squibb, orphan drugs, Revlimid
Roche and Novartis CEOs nab all-but-matching pay of 12M francs for 2016
Fierce Pharma
Fri, 03/3/17 - 09:18 am
Tags:
Roche, Novartis, Pharma CEOs, executive pay, Severin Schwan, Joe Jimenez

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.